|
Re: Additional Reports of Exempt Distribution
|
2
|
Zenith Epigenetics
|
Jul 22, 2023 07:54AM
|
|
Re: ZHCLF trading
|
2
|
Zenith Epigenetics
|
Feb 06, 2021 05:34PM
|
|
TSX review lifted finally
|
2
|
Resverlogix Corp.
|
May 10, 2018 07:37AM
|
|
Re: from IR "Hepalink does not own Zenith shares."
|
2
|
Zenith Epigenetics
|
Oct 25, 2022 06:58AM
|
|
Re: AGM
|
2
|
Resverlogix Corp.
|
Jun 20, 2023 11:45AM
|
|
Re: Seeking Alpha mention
|
2
|
Resverlogix Corp.
|
Aug 23, 2019 08:46AM
|
|
Re: Resverlogix Closes $10 Million of Equity Subscriptions
|
2
|
Resverlogix Corp.
|
Jun 20, 2017 10:02AM
|
|
Re: Investor Boomtown Posts
|
2
|
Resverlogix Corp.
|
Oct 02, 2017 12:42PM
|
|
Re: Checklist to Management
|
2
|
Resverlogix Corp.
|
Jul 30, 2016 01:15PM
|
|
Re: BETonMACE top line data
|
2
|
Resverlogix Corp.
|
Jan 16, 2018 07:27PM
|
|
Re: No news
|
2
|
Resverlogix Corp.
|
Sep 16, 2022 11:43AM
|
|
Re: BIO CEO Slides Up
|
2
|
Resverlogix Corp.
|
Feb 12, 2019 02:23PM
|
|
Re: Why is "Going it Alone" out of the question??
|
2
|
Resverlogix Corp.
|
Aug 18, 2020 02:05PM
|
|
Re: One thought I can't completely let go....
|
2
|
Resverlogix Corp.
|
Feb 15, 2019 11:00AM
|
|
Re: Symposium at ESC in Barcelona
|
2
|
Resverlogix Corp.
|
Aug 26, 2017 08:20PM
|
|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
2
|
Resverlogix Corp.
|
Jun 12, 2023 06:15PM
|
|
Re: 96 hours
|
2
|
Resverlogix Corp.
|
Aug 23, 2017 12:46PM
|
|
Re: Collaborating with the Supreme Council of the Arab-African Economy
|
2
|
Resverlogix Corp.
|
Nov 03, 2021 03:52PM
|
|
Re: ZHCLF trading
|
2
|
Zenith Epigenetics
|
Feb 07, 2021 09:28AM
|
|
Re: Positive data on cognition already 'baked in'?
|
2
|
Resverlogix Corp.
|
Dec 03, 2019 11:49AM
|
